Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| WESTELL TECH | WSTL | 5.13% |
| MAXWELL TECH | MXWL | 3.49% |
| ALLIANCE FIB | AFOP | 3.05% |
| SYNAPTICS IN | SYNA | 2.92% |
| STEIN MART I | SMRT | 2.73% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Accenture Plc. ( ACN - Snapshot Report ) recently announced that it will acquire the Singapore-based distributor management and mobility software company NewsPage Pte Ltd. for an undisclosed amount.
The acquisition is expected to strengthen the Accenture CAS software platform, which assists in the sales procedure of companies in the consumer goods industry, particularly with respect to their distributor management.
The enhancement to Accenture’s CAS solution also makes it compatible with Windows, Android and iOS devices.
Acquisitions have been a key catalyst for Accenture’s growth. In April 2012, Accenture completed the acquisition of Neo Metrics Analytics, a reputed Spanish consultant for optimization and predictive analytics. Financial terms of the buyout remained undisclosed.
Neo Metrics’ offerings facilitate interaction between companies and their customers, generating specific data to model future demand. Accenture’s Neo Metrics acquisition underscores its expansion plan in Spain. Neo Metrics’ capabilities will complement Accenture’s Analytics Innovation Center in Barcelona that became operational in April 2011.
Another important acquisition that the company made in 2011 is Zenta, a provider of residential and commercial mortgage processing services. This acquisition has helped Accenture expand its capabilities in the real estate segment by helping lenders, services and real estate investment trusts to upgrade and streamline their operations, improve customer experience and boost profitability in new markets.
We remain upbeat about deal wins from various industry verticals. We also believe Accenture’s recent acquisitions will enrich its product portfolio. However, increasing competition from IBM Inc. ( IBM - Analyst Report ) and Cognizant Technology Services ( CTSH - Analyst Report ) may dampen growth prospects to some extent.
Currently, Accenture has a Zacks #3 Rank, which implies a short-term Hold rating.
Read the full Snapshot Report on ACN
Read the full Analyst Report on IBM
Read the full Analyst Report on CTSH